Business · 14/06/2016Updated: 10/17/2026 · 1 min read
FDA Releases Draft Guidance for Industry on Osteoporosis Treatment Drugs
Summary
The Food and Drug Administration (FDA) has made available a draft guidance document outlining recommendations for the nonclinical evaluation of drugs intended to treat osteoporosis, with the aim of supporting the approval of these medications.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →